Comparison Between Continuous Versus Flash Glucose Monitoring in Children, Adolescents, and Young Adults with Type 1 Diabetes: An 8-Week Prospective Randomized Trial.
Children
Continuous glucose monitoring
Flash glucose monitoring
Hypoglycaemia
Type 1 diabetes
Journal
Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
02
06
2022
accepted:
01
07
2022
pubmed:
24
7
2022
medline:
24
7
2022
entrez:
23
7
2022
Statut:
ppublish
Résumé
To assess the impact of real-time continuous glucose monitoring (RT-CGM) instead of first-generation flash glucose monitoring (FGM) on hypoglycaemia in children and adolescents with type 1 diabetes. In this randomized controlled interventional study, young individuals with type 1 diabetes used RT-CGM or FGM for 8 weeks. We evaluated changes in time below range (TBR), severe hypoglycaemia (SH), HbA1c, glycaemic variability, and impaired awareness of hypoglycaemia with RT-CGM (intervention group) in comparison with FGM. We randomly assigned 37 participants to either the intervention group (n = 19) or the control group (n = 18). At 8 weeks, we did not find a decrease in TBR in either group, but there was a significant reduction in SH in the intervention group. For participants with TBR ≥ 5% at baseline, we observed significant reductions in 24-h TBR, wake TBR, sleep TBR, and glucose variability at 8 weeks in the intervention group. The use of RT-CGM versus FGM decreased SH in young individuals with type 1 diabetes, and TBR and glucose variability in patients with a higher TBR at baseline. The patient's history should be taken into account when advising on the method of blood glucose monitoring, as RT-CGM could be more effective in younger patients at high risk for SH. ClinicalTrials.gov NCT04249102.
Identifiants
pubmed: 35870074
doi: 10.1007/s13300-022-01297-x
pii: 10.1007/s13300-022-01297-x
pmc: PMC9399330
doi:
Banques de données
ClinicalTrials.gov
['NCT04249102']
Types de publication
Journal Article
Langues
eng
Pagination
1671-1681Informations de copyright
© 2022. The Author(s).
Références
Diabetes Technol Ther. 2021 Aug;23(8):565-576
pubmed: 33780640
Pediatr Diabetes. 2013 Nov;14(7):473-80
pubmed: 23627895
Diabetes Care. 2020 Mar;43(3):541-548
pubmed: 31882410
Pediatr Diabetes. 2011 Feb;12(1):4-10
pubmed: 20723102
Pediatr Diabetes. 2018 Oct;19 Suppl 27:178-192
pubmed: 29869358
Diabetes Care. 2010 Sep;33(9):1945-7
pubmed: 20805272
Diabetes Care. 2004 Oct;27(10):2293-8
pubmed: 15451890
Diabetologia. 2002 Jul;45(7):937-48
pubmed: 12136392
Pediatr Diabetes. 2020 Mar;21(2):300-309
pubmed: 31788937
Diabetes Technol Ther. 2021 Jul;23(7):482-490
pubmed: 33555982
Diabetologia. 1998 Aug;41(8):898-903
pubmed: 9726591
Diabetes Care. 2017 Dec;40(12):1631-1640
pubmed: 29162583
Diabetes Care. 1994 Jul;17(7):697-703
pubmed: 7924780
World J Diabetes. 2015 Feb 15;6(1):1-7
pubmed: 25685273
Diabetes Care. 2019 Aug;42(8):1593-1603
pubmed: 31177185
Intern Med J. 2021 May 5;:
pubmed: 33949770
Pediatr Diabetes. 2014 May;15(3):206-13
pubmed: 24102825
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1224-1232
pubmed: 29342264
Diabetes Technol Ther. 2019 Jun;21(6):329-335
pubmed: 31058545
J Clin Endocrinol Metab. 1994 Dec;79(6):1659-62
pubmed: 7989471
Diabetes Care. 2007 Jul;30(7):1868-70
pubmed: 17416785
J Diabetes Complications. 2017 Apr;31(4):735-741
pubmed: 28143733
Diabetes Res Clin Pract. 2019 Jun;152:111-118
pubmed: 31121275
J Pediatr Endocrinol Metab. 1998 Mar;11 Suppl 1:189-94
pubmed: 9642659
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Clin Pediatr Endocrinol. 2021;30(1):1-10
pubmed: 33446946